VANCOUVER – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) , an end-to-end drug researcher and formulator licensed by Health Canada to...
MDMA is on the cusp of FDA approval. To help give context, this article dives into the history of MDMA research The post A Look at...
The Canadian psychedelics company reported a loss of C$7.6 million for the first quarter. The post Mydecine Loss Rate Increases, Only C$10k Left On Hand...
As we move into the 2nd quarter of 2023, we take a look at Q1 and other trends in the psychedelic medicine sector The post Q1...
The Church of Psilomethoxin claims it’s the victim of “psychedelic capitalism,” but almost everything it claims is wrong. The post Church of Psilomethoxin,...
How far has the psychedelics medicines industry come over the past 12 months? Well, it depends on where you look. 11 investors predict a colorful, if...
Oregon, the first state to legalize psilocybin therapy services, continues to roll out the foundations of its new psychedelic medicine industry. Back in...
Though psychedelics are gaining mainstream support from media and patients alike, the medical institution is not as quick to voice its unwavering support....
Natural products include probiotics, herbal remedies, vitamins and minerals, homeopathic medicines, traditional medicines among others The post Optimi...
VANCOUVER – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), an end-to-end drug researcher and formulator licensed by Health Canada to produce...